Life Sciences is Our Business
Founded in 2004, Pontifax is a healthcare-dedicated venture capital firm with over $775 million under management. We seek transformative, cutting-edge life sciences technologies at all development stages. Our portfolio comprises of about 80 companies that develop breakthrough solutions to substantial unmet needs.
Pontifax began with the vision of our co-founder and chairman Eli Hurvitz (1932-2011), the legendary CEO and chairman of Teva Pharmaceuticals who spearheaded its strategy to become one of the world’s largest pharmaceutical companies. Under Eli’s guidance, we accumulated the experience and acquired the know-how required to foster life sciences innovations from inception to full-fledged, viable, operating companies. Eli’s legacy continues to guide our choices and decisions today.
Pontifax invests in breakthrough innovation regardless of therapeutic area or development stage. We establish our own companies as well as partner with existing managements to nurture start-ups to maturity. Pontifax takes a hands-on approach in its portfolio management and is deeply involved in charting the course of each company.